Your browser doesn't support javascript.
loading
Liver cirrhosis leads to poorer survival in patients with end-stage renal disease.
Kim, Ae Jin; Lim, Hye Jin; Ro, Han; Jung, Ji Yong; Lee, Hyun Hee; Chung, Wookyung; Chang, Jae Hyun.
Afiliação
  • Kim AJ; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Lim HJ; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Ro H; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Jung JY; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Lee HH; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Chung W; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
  • Chang JH; Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University, Incheon, Korea.
Korean J Intern Med ; 31(4): 730-8, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27017394
ABSTRACT
BACKGROUND/

AIMS:

Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mortality betweentwo dialysis modalities.

METHODS:

Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolledin the present study from 2000 to 2011. We analyzed 1,069 patients withESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patientswere undergoing peritoneal dialysis (PD).

RESULTS:

The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-,3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively,whereas the equivalent survival rates of cirrhotic patients were 90%,68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independentrisk factor for death in patients with ESRD. No difference in mortality associatedwith LC was found between the HD and PD subgroups.

CONCLUSIONS:

Of the patients with ESRD, cirrhotic patients had poorer survivalthan noncirrhotic patients. Among patients with ESRD and LC, survival of patientsundergoing PD may be comparable with that of patients undergoing HD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diálise Renal / Diálise Peritoneal / Falência Renal Crônica / Cirrose Hepática Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Korean J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diálise Renal / Diálise Peritoneal / Falência Renal Crônica / Cirrose Hepática Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Korean J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2016 Tipo de documento: Article